Molecules 2019, 24, 1581
29 of 30
29. Wang, T.; Yin, Z.; Zhang, Z.; Bender, J.A.; Yang, Z.; Johnson, G.; Yang, Z.; Zadjura, L.M.; D’Arienzo, C.J.; Parker, D.D.;
et al. Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to
Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)
ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects.
J. Med. Chem. 2009, 52, 7778–7787.
30. Meanwell, N.A.; Wallace, O.B.; Fang, H.; Wang, H.; Deshpande, M.; Wang, T.; Yin, Z.; Zhang, Z.; Pearce, B.C.;
James, J.; et al. Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns.
Bioorganic Med. Chem. Lett. 2009, 19, 1977–1981. [CrossRef]
31. Wang,T.; Zhang,Z.; Wallace,O.B.; Deshpande,M.; Fang,H.; Yang,Z.; Zadjura,L.M.; Tweedie,D.L.; Huang,S.; Zhao,F.;
et al. Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine
(BMS-378806): A novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions. J. Med. Chem. 2003
,
32. Xu, J.P.; Francis, A.C.; Meuser, M.E.; Mankowski, M.; Ptak, R.G.; Rashad, A.A.; Melikyan, G.B.; Cocklin, S.
Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action. J. Drug
Des. Res. 2018, 5.
33. Connor, R.I.; Chen, B.K.; Choe, S.; Landau, N.R. Vpr Is Required for Efficient Replication of Human
Immunodeficiency Virus Type-1 in Mononuclear Phagocytes. Virology 1995, 206, 935–944. [CrossRef]
34. Allan, J.; Coligan, J.; Barin, F.; McLane, M.; Sodroski, J.; Rosen, C.; Haseltine, W.; Lee, T.; Essex, M. Major glycoprotein
antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 1985, 228, 1091–1094. [CrossRef]
35. Koyanagi, Y.; O’Brien, W.; Zhao, J.; Golde, D.; Gasson, J.; Chen, I. Cytokines alter production of HIV-1 from
primary mononuclear phagocytes. Science 1988, 241, 1673–1675. [CrossRef]
36. Koyanagi, Y.; Miles, S.; Mitsuyasu, R.; Merrill, J.; Vinters, H.; Chen, I. Dual infection of the central nervous
system by AIDS viruses with distinct cellular tropisms. Science 1987, 236, 819–822. [CrossRef]
37. O’Brien, W.A.; Koyanagi, Y.; Namazie, A.; Zhao, J.-Q.; Diagne, A.; Ldler, K.; A Zack, J.; Chen, I.S.Y. HIV-1
tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding
domain. Nat. Cell Boil. 1990, 348, 69–73. [CrossRef]
38. Li, Y.; Hui, H.; Burgess, C.J.; Price, R.W.; Sharp, P.M.; Hahn, B.H.; Shaw, G.M. Complete nucleotide sequence,
genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: Evidence
for limited defectiveness and complementation. J. Virol. 1992, 66, 6587–6600. [PubMed]
39. Li, Y.; Kappes, J.C.; A Conway, J.; Price, R.W.; Shaw, G.M.; Hahn, B.H. Molecular characterization of human
immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of
replication-competent and -defective viral genomes. J. Virol. 1991, 65, 3973–3985.
40. Björndal, A.; Deng, H.; Jansson, M.; Fiore, J.R.; Colognesi, C.; Karlsson, A.; Albert, J.; Scarlatti, G.; Littman, D.R.;
Fenyö, E.M. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to
biological phenotype. J. Virol. 1997, 71, 7478–7487. [PubMed]
41. Zentner, I.; Sierra, L.-J.; Fraser, A.K.; Maciunas, L.; Mankowski, M.K.; Vinnik, A.; Fedichev, P.; Ptak, R.G.;
Martín-García, J.; Cocklin, S.; et al. Identification of a Small-Molecule Inhibitor of HIV-1 Assembly that
Targets the Phosphatidylinositol (4,5)-bisphosphate Binding Site of the HIV-1 Matrix Protein. ChemMedChem
42. Kortagere, S.; Madani, N.; Mankowski, M.K.; Schon, A.; Zentner, I.; Swaminathan, G.; Princiotto, A.;
Anthony, K.; Oza, A.; Sierra, L.J.; et al. Inhibiting early-stage events in HIV-1 replication by small-molecule
targeting of the HIV-1 capsid. J. Virol. 2012, 86, 8472–8481. [CrossRef] [PubMed]
43. Studier, F.W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 2005
,
44. Hofmann, W.; Schubert, D.; LaBonte, J.; Munson, L.; Gibson, S.; Scammell, J.; Ferrigno, P.; Sodroski, J. Species-Specific,
Postentry Barriers to Primate Immunodeficiency Virus Infection. J. Virol. 1999, 73, 10020–10028.
45. Marcon, L.; Choe, H.; A Martin, K.; Farzan, M.; Ponath, P.D.; Wu, L.; Newman, W.; Gerard, N.; Gerard, C.;
Sodroski, J. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian
immunodeficiency virus, SIVmac239. J. Virol. 1997, 71, 2522–2527.
46. Ratner, L.; Haseltine, W.; Patarca, R.; Livak, K.J.; Starcich, B.; Josephs, S.F.; Doran, E.R.; Rafalski, J.A.; Whitehorn, E.A.;
Baumeister, K.; et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nat. Cell Boil. 1985, 313, 277–284.